Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T van der Poll

Showing results (161-170 of 227) with videos related to

Pageof 23
Sort By:
Thrombosis and Haemostasis|January 1, 1996
Fat emulsion infusion potentiates coagulation activation during human endotoxemiaT van der Poll, S M Coyle, M Levi, et al.
Blood|February 1, 1992
Effects on leukocytes after injection of tumor necrosis factor into healthy humansT van der Poll, S J van Deventer, C E Hack, et al.
Journal of Thrombosis and Haemostasis : JTH|June 30, 2006
Vagus nerve stimulation inhibits activation of coagulation and fibrinolysis during endotoxemia in ratsD J van Westerloo, I A J Giebelen, J C M Meijers, et al.
Kidney International|October 13, 2006
The urokinase plasminogen activator receptor is crucially involved in host defense during acute pyelonephritisJ J T H Roelofs, K M A Rouschop, G J D Teske, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1994
Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzeesB Kuipers, T van der Poll, M Levi, et al.
Scandinavian Journal of Gastroenterology|November 26, 1998
Reduction of circulating secretory phospholipase A2 levels by anti-tumor necrosis factor chimeric monoclonal antibody in patients with severe Crohn's disease. Relation between tumor necrosis factor and secretory phospholipase A2 in healthy humans and in active Crohn's diseaseH M van Dullemen, G J Wolbink, P C Wever, et al.
Infection and Immunity|July 23, 1999
Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannanN P Juffermans, A Verbon, S J van Deventer, et al.
Gastroenterology|May 16, 2006
The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in miceDavid J van Westerloo, Ilona A Giebelen, Sandrine Florquin, et al.
Blood|September 25, 1999
The effect of a metalloproteinase inhibitor (GI5402) on tumor necrosis factor-alpha (TNF-alpha) and TNF-alpha receptors during human endotoxemiaP E Dekkers, F N Lauw, T ten Hove, et al.
Blood|August 1, 1995
Contribution of interleukin-1 to activation of coagulation and fibrinolysis, neutrophil degranulation, and the release of secretory-type phospholipase A2 in sepsis: studies in nonhuman primates after interleukin-1 alpha administration and during lethal bacteremiaP M Jansen, M A Boermeester, E Fischer, et al.
Pageof 23

Showing results (161-170 of 227) with videos related to

Sort By:
Pageof 23
Thrombosis and Haemostasis|January 1, 1996
Fat emulsion infusion potentiates coagulation activation during human endotoxemiaT van der Poll, S M Coyle, M Levi, et al.
Blood|February 1, 1992
Effects on leukocytes after injection of tumor necrosis factor into healthy humansT van der Poll, S J van Deventer, C E Hack, et al.
Journal of Thrombosis and Haemostasis : JTH|June 30, 2006
Vagus nerve stimulation inhibits activation of coagulation and fibrinolysis during endotoxemia in ratsD J van Westerloo, I A J Giebelen, J C M Meijers, et al.
Kidney International|October 13, 2006
The urokinase plasminogen activator receptor is crucially involved in host defense during acute pyelonephritisJ J T H Roelofs, K M A Rouschop, G J D Teske, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1994
Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzeesB Kuipers, T van der Poll, M Levi, et al.
Scandinavian Journal of Gastroenterology|November 26, 1998
Reduction of circulating secretory phospholipase A2 levels by anti-tumor necrosis factor chimeric monoclonal antibody in patients with severe Crohn's disease. Relation between tumor necrosis factor and secretory phospholipase A2 in healthy humans and in active Crohn's diseaseH M van Dullemen, G J Wolbink, P C Wever, et al.
Infection and Immunity|July 23, 1999
Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannanN P Juffermans, A Verbon, S J van Deventer, et al.
Gastroenterology|May 16, 2006
The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in miceDavid J van Westerloo, Ilona A Giebelen, Sandrine Florquin, et al.
Blood|September 25, 1999
The effect of a metalloproteinase inhibitor (GI5402) on tumor necrosis factor-alpha (TNF-alpha) and TNF-alpha receptors during human endotoxemiaP E Dekkers, F N Lauw, T ten Hove, et al.
Blood|August 1, 1995
Contribution of interleukin-1 to activation of coagulation and fibrinolysis, neutrophil degranulation, and the release of secretory-type phospholipase A2 in sepsis: studies in nonhuman primates after interleukin-1 alpha administration and during lethal bacteremiaP M Jansen, M A Boermeester, E Fischer, et al.
Pageof 23